| Ike Armstrong Onwere, MD | |
|
501 Nw Elks Dr, Suite 100, Corvallis, OR 97330-3757 | |
| (541) 768-4950 | |
| (541) 768-4951 |
| Full Name | Ike Armstrong Onwere |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 23 Years |
| Location | 501 Nw Elks Dr, Corvallis, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467454025 | NPI | - | NPPES |
| 100768880I | Medicaid | OK | |
| 20003300A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD150690 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Blanchard Valley Hospital | Findlay, OH | Hospital |
| Bluffton Hospital | Bluffton, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blanchard Valley Regional Health Center | 3971404187 | 78 |
News Archive
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response rate of 33 percent of treated patients with early-stage, resectable non-small cell lung cancers, meaning these patients had less than or equal to 10 percent viable tumor remaining at surgery.
The National Children's Health Survey published results from a 2007 telephone survey in Pediatrics today in which 78,000 households in the US were asked if their child (ages 2-17) was known to "currently have autism, Asperger's Disorder, pervasive development disorder, or other autism spectrum disorder." The survey showed that 1% of children (one in 100) now have the disorder. Previous estimates from the CDC had reported a prevalence rate of one in 150.
ZEISS recently announced ZEISS ZEN Intellesis, a new machine learning capability that enables researchers to perform advanced analysis of their imaging samples across multiple microscopy methods.
The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer. In an upcoming issue of the journal Cancer (online today), Indiana University researchers report four of 10 patients who participated in a phase I clinical trial had no disease progression after six months of treatment. One patient experienced complete resolution of tumor tissue for a period of time.
According to a new study, there is a rising trend of sexting among teenagers and younger children over the last decade and this may be a challenge for carers and parents alike.
› Verified 4 days ago
| Entity Name | Blanchard Valley Regional Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083665251 PECOS PAC ID: 3971404187 Enrollment ID: O20040120000179 |
News Archive
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response rate of 33 percent of treated patients with early-stage, resectable non-small cell lung cancers, meaning these patients had less than or equal to 10 percent viable tumor remaining at surgery.
The National Children's Health Survey published results from a 2007 telephone survey in Pediatrics today in which 78,000 households in the US were asked if their child (ages 2-17) was known to "currently have autism, Asperger's Disorder, pervasive development disorder, or other autism spectrum disorder." The survey showed that 1% of children (one in 100) now have the disorder. Previous estimates from the CDC had reported a prevalence rate of one in 150.
ZEISS recently announced ZEISS ZEN Intellesis, a new machine learning capability that enables researchers to perform advanced analysis of their imaging samples across multiple microscopy methods.
The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer. In an upcoming issue of the journal Cancer (online today), Indiana University researchers report four of 10 patients who participated in a phase I clinical trial had no disease progression after six months of treatment. One patient experienced complete resolution of tumor tissue for a period of time.
According to a new study, there is a rising trend of sexting among teenagers and younger children over the last decade and this may be a challenge for carers and parents alike.
› Verified 4 days ago
| Entity Name | Specialty Physicians Of Blanchard Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689835415 PECOS PAC ID: 2668547613 Enrollment ID: O20080826000542 |
News Archive
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response rate of 33 percent of treated patients with early-stage, resectable non-small cell lung cancers, meaning these patients had less than or equal to 10 percent viable tumor remaining at surgery.
The National Children's Health Survey published results from a 2007 telephone survey in Pediatrics today in which 78,000 households in the US were asked if their child (ages 2-17) was known to "currently have autism, Asperger's Disorder, pervasive development disorder, or other autism spectrum disorder." The survey showed that 1% of children (one in 100) now have the disorder. Previous estimates from the CDC had reported a prevalence rate of one in 150.
ZEISS recently announced ZEISS ZEN Intellesis, a new machine learning capability that enables researchers to perform advanced analysis of their imaging samples across multiple microscopy methods.
The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer. In an upcoming issue of the journal Cancer (online today), Indiana University researchers report four of 10 patients who participated in a phase I clinical trial had no disease progression after six months of treatment. One patient experienced complete resolution of tumor tissue for a period of time.
According to a new study, there is a rising trend of sexting among teenagers and younger children over the last decade and this may be a challenge for carers and parents alike.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ike Armstrong Onwere, MD 501 Nw Elks Dr, Suite 100, Corvallis, OR 97330-3757 Ph: (541) 768-4950 | Ike Armstrong Onwere, MD 501 Nw Elks Dr, Suite 100, Corvallis, OR 97330-3757 Ph: (541) 768-4950 |
News Archive
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response rate of 33 percent of treated patients with early-stage, resectable non-small cell lung cancers, meaning these patients had less than or equal to 10 percent viable tumor remaining at surgery.
The National Children's Health Survey published results from a 2007 telephone survey in Pediatrics today in which 78,000 households in the US were asked if their child (ages 2-17) was known to "currently have autism, Asperger's Disorder, pervasive development disorder, or other autism spectrum disorder." The survey showed that 1% of children (one in 100) now have the disorder. Previous estimates from the CDC had reported a prevalence rate of one in 150.
ZEISS recently announced ZEISS ZEN Intellesis, a new machine learning capability that enables researchers to perform advanced analysis of their imaging samples across multiple microscopy methods.
The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer. In an upcoming issue of the journal Cancer (online today), Indiana University researchers report four of 10 patients who participated in a phase I clinical trial had no disease progression after six months of treatment. One patient experienced complete resolution of tumor tissue for a period of time.
According to a new study, there is a rising trend of sexting among teenagers and younger children over the last decade and this may be a challenge for carers and parents alike.
› Verified 4 days ago
Tomer Pelleg, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3600 Nw Samaritan Dr Ste 227, Corvallis, OR 97330 Phone: 541-768-1261 | |
Dr. Parinav Kanwar, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-4906 | |
Dr. Stanley J. Nudelman, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3521 Nw Samaritan Dr, Suite 201, Corvallis, OR 97330 Phone: 541-768-5140 | |
Dr. Randall V. Bream, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3600 Nw Samaritan Dr, Suite E350, Corvallis, OR 97330 Phone: 541-768-5205 Fax: 541-768-5206 | |
Jonathan David Jones, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3620 Nw Samaritan Dr Ste 202, Corvallis, OR 97330 Phone: 541-768-5800 | |
Gemechu Abraham Geleto, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-4906 | |
Roland Solensky, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3680 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-754-1150 |